Wednesday, October 27, 2021
More

    Latest Posts

    CDC panel backs BioNTech/Pfizer booster for elderly and at-risk groups

    Newsletter: The Road to Recovery

    The Biden administration’s plans for an extensive Covid-19 booster program suffered another blow on Thursday. A panel of scientists advising the best public health agencies recommended that the third dose be given only to the elderly, caregiver residents, and people with underlying health problems. ..

    The Vaccine Commission, which advises the US Centers for Disease Control and Prevention, recommends boosters of the BioNTech / Pfizer vaccine for people over the age of 65 and home caregivers, with 13-2 adding to the underlying people aged 50-64. It was unanimously approved to approve the vaccination. Medical condition.

    The Commission cast 9-6 votes to provide boosters to people over the age of 18 with underlying health. However, with 9-6 votes, they refused to approve a third jab for those working in jobs at high risk of exposure to Covid.

    The Biden administration planned to launch an extensive program for all Americans over the age of 16 starting next week, even before regulatory approvals. It offended some scientists, retirement Two top FDA executives earlier this month

    The FDA’s advisory board then refused to recommend the BioNTech / Pfizer booster to anyone over the age of 16 and instead recommended a more limited group of older, at-risk individuals. The FDA took note of the recommendation on Wednesday. Approval A third dose to people over the age of 65 and adults at high risk for severe Covid-19, or adults whose work is frequently exposed to the virus.

    The CDC Committee recommended a narrower set of qualifications after some members asked whether the need for additional doses outweighed the potential risks, especially in younger people.

    Some scientists questioned the logistics of giving boosters only to people who received the BioNTech / Pfizer vaccine and complained about the lack of data on booster doses for the single-shot Johnson & Johnson vaccine.

    “I don’t know what I can say to people over the age of 65.” You are at serious risk of hospitalization. .. .. But for now, only half of you can protect yourself, “said Sarah Long, a pediatric professor at Drexel University School of Medicine.

    Scientists continue to prioritize complete vaccination, defined as a second dose of mRNA jab, such as that produced by BioNTech / Pfizer and Moderna, or two weeks after a single J & J shot. I paid attention to it. The FDA has already approved a third dose of mRNA vaccine for people with weakened immune systems.

    Some members questioned the range of data available. Camille Cotton, an infectious disease specialist at Massachusetts General Hospital, said blacks and Latin people under the age of 65 were dead and needed more data to reflect their ethnicity. “It’s not the same result across all racial groups,” she said.

    CDC panel backs BioNTech/Pfizer booster for elderly and at-risk groups Source link CDC panel backs BioNTech/Pfizer booster for elderly and at-risk groups

    The post CDC panel backs BioNTech/Pfizer booster for elderly and at-risk groups appeared first on California News Times.

    Source link

    Latest Posts

    Don't Miss

    Stay in touch

    To be updated with all the latest news, offers and special announcements.